NTRB
Nutriband Inc

2,435
Loading...
Loading...
News
all
press releases
Nutriband Inc. (NTRB) Reports Q2 Loss, Lags Revenue Estimates
Nutriband (NTRB) delivered earnings and revenue surprises of -1,147.06% and -11.77%, respectively, for the quarter ended July 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·7d ago
News Placeholder
More News
News Placeholder
Phibro Animal Health (PAHC) Tops Q4 Earnings and Revenue Estimates
Phibro (PAHC) delivered earnings and revenue surprises of +9.62% and +4.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·20d ago
News Placeholder
MediWound (MDWD) Reports Q2 Loss, Beats Revenue Estimates
MediWound (MDWD) delivered earnings and revenue surprises of -123.64% and +1.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
ARS Pharmaceuticals, Inc. (SPRY) Reports Q2 Loss, Beats Revenue Estimates
ARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of -12.20% and +3.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Assertio (ASRT) Reports Q2 Loss, Beats Revenue Estimates
Assertio (ASRT) delivered earnings and revenue surprises of -70.00% and +4.55%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Aclaris Therapeutics (ACRS) Reports Q2 Loss, Beats Revenue Estimates
Aclaris (ACRS) delivered earnings and revenue surprises of 0.00% and +14.42%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Nutriband begins manufacturing for Fit For Life Group
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·1y ago
News Placeholder
Nutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New Balance
ORLANDO, FL / ACCESSWIRE / April 1, 2024 / Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a pharmaceutical company with a specific focus on transdermal technologies, today announces it has been engaged...
Accesswire·1y ago
News Placeholder
Is Nutriband (NASDAQ:NTRB) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
Simply Wall St·1y ago
News Placeholder
Nutriband Provides Clinical and Regulatory Path Overview for Lead Product - AVERSA(R) Fentanyl Transdermal Patch
NDA will be primarily based on a single Phase 1 human abuse potential clinical study with no Phase 2 or 3 clinical trials needed prior to submission.AVERSA(TM) Fentanyl incorporates Nutriband's...
Accesswire·1y ago

Latest NTRB News

View

Advertisement. Remove ads.

Advertisement. Remove ads.